Skip to main content
Premium Trial:

Request an Annual Quote

Aptiv, Cancer Genetics Ink Partnership Directed at Cancer Clinical Trials

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Aptiv Solutions today announced a partnership with Cancer Genetics for products and services directed at oncology clinical trials.

The two firms did not specify what products or services will result from the deal, but Aptiv said in a statement that they will provide "biopharmaceutical firms with a better understanding of modes of action of a variety of therapeutics and the role of biomarkers in the oncology drug development process."

"The collaboration will provide customers with the products and services necessary to bring oncology therapeutics to their patients faster and at a reduced cost," the Great Falls, Va.-based firm added.

Financial and other terms of the deal were not disclosed.

Aptiv is a biopharmaceutical and medical device development services organization. Among the services it provides are adaptive trial design, early phase product strategy, regulatory services, pharmacovigilance, "and the operational support of a global clinical research organization," it said.

CGI, based in Rutherford, NJ, provides expertise in disease-specific biomarkers, proprietary molecular testing, and oncology lab services to companies in the early stages of clinical trials.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.